US Senator John McCain and risk of melanoma-associated mortality

The Lancet

Volumn 372, Issue 9648, 2008, Pages 1462-

  Alam, John ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; HEALTH STATUS; HUMAN; LETTER; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; PUBLIC FIGURE; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; UNITED STATES;

EID: 54349088566     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61618-9     Document Type: Letter

References (5)

1. Statement of health status: prepared by Mayo Clinic at the request of Senator John McCain. http://www.johnmccain.com/mccainrecords/ (accessed Sept 10, 2008).
2. Schuchter L., Schultz D.J., Synnestvedt M., et al. A prognostic model for predicting 10-year survival in patients with primary melanoma. Ann Intern Med 125 (1996) 369-375
3. Kolmel K.F., Kulle B., Lippold A., and Seebacher C. Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy. Eur J Cancer 38 (2002) 1388-1394
4. Leong S.P., Accortt N., Essner R., et al. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg 132 (2006) 370-373
5. Gomez-Rivera F., Santillan A., McMurphey A.B., et al. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study. Head Neck 30 (2008) 1284-1294